Subunit vaccine of PCV3 capsid protein produced by sf9 cells with double knockout of Caspase-1 and Dronc induces strong immune response in mice

IF 2.7 2区 农林科学 Q3 MICROBIOLOGY Veterinary microbiology Pub Date : 2025-03-04 DOI:10.1016/j.vetmic.2025.110452
Shuo Li , Ruihong Guo , Yinxiang Fang , Chunhong Zhang , Linyu Jiang , Weixin Jia , Zhangyong Ning
{"title":"Subunit vaccine of PCV3 capsid protein produced by sf9 cells with double knockout of Caspase-1 and Dronc induces strong immune response in mice","authors":"Shuo Li ,&nbsp;Ruihong Guo ,&nbsp;Yinxiang Fang ,&nbsp;Chunhong Zhang ,&nbsp;Linyu Jiang ,&nbsp;Weixin Jia ,&nbsp;Zhangyong Ning","doi":"10.1016/j.vetmic.2025.110452","DOIUrl":null,"url":null,"abstract":"<div><div>Porcine circovirus type 3 (PCV3) associated with multisystemic clinicopathological diseases in swine herds has caused economic losses and there is no available commercial vaccine. Production of PCV3 capsid protein (Cap) by <em>Spodoptera frugiperda 9</em> (sf9) cells using baculovirus expression vector system (BEVS) is a valid strategy to develop vaccines. Here, we report that subunit vaccine of PCV3 produced by sf9 cells with double knockout of <em>Caspase-1</em> and <em>Dronc</em> genes induces strong immune response in mice. Three kinds of knockout sf9 cells aimed at <em>Caspase-1</em> gene, <em>Dronc</em> gene and both genes were successfully generated by clustered regularly interspaced short palindromic repeats-associated protein 9 (CRISPR-Cas9) system, and sequence analysis confirmed this. The anti-apoptosis ability of three kinds of knockout sf9 cells was assessed, and double knockout sf9 cells are the best. The expression of PCV3 Cap was enhanced in double knockout sf9 cells compared to wild type sf9 cells, and subunit vaccines were produced by PCV3 Cap expressed from double knockout sf9 cells and wild type cells, respectively. Results of immunological experiment in mice showed subunit vaccine of PCV3 Cap from double knockout sf9 cells induces higher level of serum antibody, stimulates lymphocyte proliferation and enhances expression of IL-2, IFN-γ, IL-4 and IL-10 compared to wild type cells. These results present knockout sf9 cells to enhance the expression of protein in BEVS, and provide a technical platform for vaccine development of PCV3.</div></div>","PeriodicalId":23551,"journal":{"name":"Veterinary microbiology","volume":"304 ","pages":"Article 110452"},"PeriodicalIF":2.7000,"publicationDate":"2025-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Veterinary microbiology","FirstCategoryId":"97","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0378113525000872","RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Porcine circovirus type 3 (PCV3) associated with multisystemic clinicopathological diseases in swine herds has caused economic losses and there is no available commercial vaccine. Production of PCV3 capsid protein (Cap) by Spodoptera frugiperda 9 (sf9) cells using baculovirus expression vector system (BEVS) is a valid strategy to develop vaccines. Here, we report that subunit vaccine of PCV3 produced by sf9 cells with double knockout of Caspase-1 and Dronc genes induces strong immune response in mice. Three kinds of knockout sf9 cells aimed at Caspase-1 gene, Dronc gene and both genes were successfully generated by clustered regularly interspaced short palindromic repeats-associated protein 9 (CRISPR-Cas9) system, and sequence analysis confirmed this. The anti-apoptosis ability of three kinds of knockout sf9 cells was assessed, and double knockout sf9 cells are the best. The expression of PCV3 Cap was enhanced in double knockout sf9 cells compared to wild type sf9 cells, and subunit vaccines were produced by PCV3 Cap expressed from double knockout sf9 cells and wild type cells, respectively. Results of immunological experiment in mice showed subunit vaccine of PCV3 Cap from double knockout sf9 cells induces higher level of serum antibody, stimulates lymphocyte proliferation and enhances expression of IL-2, IFN-γ, IL-4 and IL-10 compared to wild type cells. These results present knockout sf9 cells to enhance the expression of protein in BEVS, and provide a technical platform for vaccine development of PCV3.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
通过双敲除Caspase-1和Dronc, sf9细胞产生PCV3衣壳蛋白亚单位疫苗,可诱导小鼠产生较强的免疫应答
与猪群多系统临床病理疾病相关的3型猪圆环病毒(PCV3)造成了经济损失,而且没有可用的商业疫苗。利用杆状病毒表达载体系统(BEVS)在frugiperda Spodoptera 9 (sf9)细胞中生产PCV3衣壳蛋白(Cap)是一种有效的疫苗开发策略。在这里,我们报道了由双敲除Caspase-1和Dronc基因的sf9细胞产生的PCV3亚单位疫苗在小鼠中诱导强烈的免疫应答。利用聚类规则间隔短回文重复序列相关蛋白9 (CRISPR-Cas9)系统成功产生了针对Caspase-1基因、Dronc基因及两种基因的三种敲除sf9细胞,序列分析证实了这一点。对三种敲除sf9细胞的抗凋亡能力进行了评价,以双敲除sf9细胞的抗凋亡能力最好。与野生型sf9细胞相比,双敲除sf9细胞中PCV3 Cap的表达增强,用双敲除sf9细胞和野生型细胞分别表达PCV3 Cap制备亚单位疫苗。小鼠免疫实验结果显示,与野生型细胞相比,双敲除sf9细胞的PCV3 Cap亚单位疫苗可诱导更高水平的血清抗体,刺激淋巴细胞增殖,增强IL-2、IFN-γ、IL-4和IL-10的表达。这些结果表明敲除sf9细胞可增强BEVS中蛋白的表达,为PCV3疫苗的开发提供了技术平台。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Veterinary microbiology
Veterinary microbiology 农林科学-兽医学
CiteScore
5.90
自引率
6.10%
发文量
221
审稿时长
52 days
期刊介绍: Veterinary Microbiology is concerned with microbial (bacterial, fungal, viral) diseases of domesticated vertebrate animals (livestock, companion animals, fur-bearing animals, game, poultry, fish) that supply food, other useful products or companionship. In addition, Microbial diseases of wild animals living in captivity, or as members of the feral fauna will also be considered if the infections are of interest because of their interrelation with humans (zoonoses) and/or domestic animals. Studies of antimicrobial resistance are also included, provided that the results represent a substantial advance in knowledge. Authors are strongly encouraged to read - prior to submission - the Editorials (''Scope or cope'' and ''Scope or cope II'') published previously in the journal. The Editors reserve the right to suggest submission to another journal for those papers which they feel would be more appropriate for consideration by that journal. Original research papers of high quality and novelty on aspects of control, host response, molecular biology, pathogenesis, prevention, and treatment of microbial diseases of animals are published. Papers dealing primarily with immunology, epidemiology, molecular biology and antiviral or microbial agents will only be considered if they demonstrate a clear impact on a disease. Papers focusing solely on diagnostic techniques (such as another PCR protocol or ELISA) will not be published - focus should be on a microorganism and not on a particular technique. Papers only reporting microbial sequences, transcriptomics data, or proteomics data will not be considered unless the results represent a substantial advance in knowledge. Drug trial papers will be considered if they have general application or significance. Papers on the identification of microorganisms will also be considered, but detailed taxonomic studies do not fall within the scope of the journal. Case reports will not be published, unless they have general application or contain novel aspects. Papers of geographically limited interest, which repeat what had been established elsewhere will not be considered. The readership of the journal is global.
期刊最新文献
GRP78 interacts with the Nsp3 of porcine deltacoronavirus and inhibits viral replication Japanese encephalitis virus envelope protein activates the TLR4/NF‑κB pathway to induce testicular inflammation TGEV infection activates pro‑inflammatory signaling via the YY1/HSP40/NF‑κB pathway in intestinal epithelial cells and organoids Computation-driven discovery of a next-generation canine monoclonal antibody for canine parvovirus therapy Equine neorickettsiosis: A global perspective of the natural habitat of the bacteria and clinical disease
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1